North America In-Vitro Toxicology Testing Market Size is USD 524.05 Million in 2026

North America In-Vitro Toxicology Testing Market (By Technology: Cell Culture Technology, High Throughput Technology, Molecular Imaging Technology, OMICS Technology; By Product: Consumables, Assays, Instruments, Software, Services; By Method: Cellular Assay, Live Cells, High Throughput / High Content Screening, Molecular Imaging, Confocal Microscopy, Fixed Cells, Biochemical Assay, In Silico, Ex-vivo, Others; By Application: Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Others; By End-use: Pharmaceutical Industry, Cosmetics & Household Products, Academic Institutes & Research Laboratories, Diagnostics, Chemicals Industry, Food Industry) Industry Size, Share, Growth, Trends, 2026 to 2035.

Report Code : 1033  |  Published : 22 May 2026   |  Delivery : Immediate   |  Format : Excel   |  Author : Aditi Shivarkar, Aman Singh
Revenue,
USD 470 Mn
Forecast Year,
USD 1,395.88 Mn
CAGR, 2026 - 2035
11.50%
Report Coverage
North America
Download Databook

The North America in-vitro toxicology testing market size surpassed USD 470.00 million in 2025 and is predicted to reach around USD 1,395.88 million by 2035, registering a CAGR of 11.50% from 2026 to 2035. The market is expected to grow due to higher demand for non-animal testing of various chemical substances, especially by the pharmaceutical companies.

North America In-Vitro Toxicology Testing Market Statical Scope

Reports Attributes Statistics
Market Size in 2025 USD 470.00 Million
Market Size in 2026 USD 524.05 Million
Market Size by 2035 USD 1,395.88 Million
CAGR 2026 to 2035 11.50%
Base Year 2025
Forecast Period 2026 to 2035

The North America in-vitro toxicology testing market is also propelled due to the adoption of 3D cell cultures, organ-on-a-chip technologies, and regulatory support for alternatives. Major shift of the U.S. FDA and EPA encouraging non-animal testing methods and following ethical, validated, and faster, in-vitro assays, also helps to fuel the growth of the market.

North America In-Vitro Toxicology Testing Market Share, By Technolog, 2025 (%)

Segments Shares (%)
Cell Culture Technology 35%
High Throughput Technology 30%
Molecular Imaging Technology 20%
OMICS Technology 15%
  • Cell Culture Technology- The dominating segment holds 35% of the market share and is driven by its extensive use in toxicity screening and ability to replicate human biological responses.
  • High Throughput Technology- The segment has a significant share of 30% and is supported by increasing demand for rapid and large-scale toxicity testing.

North America In-Vitro Toxicology Testing Market Share, By Product, 2025 (%)

Segments Shares (%)
Consumables 30%
Assays 25%
Instruments 20%
Software 10%
Services 15%
  • Consumables- The dominating segment holds 30% of the market share and is propelling due to its recurring usage in testing procedures and its higher demand.
  • Assays- The segment has a notable share of 25% and is growing due to its vital role in toxicity detection and analysis.

North America In-Vitro Toxicology Testing Market, By Method Share, By Solution, 2025 (%)

Segments Shares (%)
Cellular Assay 40%
Biochemical Assay 25%
In Silico 20%
Ex-vivo 15%
  • Cellular Assay- The dominating segment holds 40% of the market share and is growing due to its higher usage for evaluating toxic effects at the cellular level.
  • Biochemical Assay- The segment has a notable share of 25% and is vital due to its essential role in analyzing biochemical interactions and toxicity pathways.

North America In-Vitro Toxicology Testing Market, By Application Market Share, By Solution, 2025 (%)

Segments Shares (%)
Systemic Toxicology 30%
Dermal Toxicity 21%
Endocrine Disruption 19%
Ocular Toxicity 16%
Others 14%
  • Systemic Toxicology- The dominating segment reflects 30% of the market share and is driven by the need to assess overall toxic effects on the human body.
  • Dermal Toxicity- The segment has a notable share of 21% and is growing due to increasing testing requirements for cosmetics and topical products.

North America In-Vitro Toxicology Testing Market, By End Use Market Share, By Solution, 2025 (%)

Segments Shares (%)
Pharmaceutical Industry 35%
Academic Institutes & Research Laboratories 20%
Cosmetics and Household Products 15%
Diagnostics 13%
Food Industry 9%
Chemicals Industry 8%
  • Pharmaceutical Industry- The segment has a significant share of 35% and is dominating due to its extensive use of in-vitro toxicology testing in drug development and safety assessment.
  • Cosmetics and Household Products- The segment holds 15% of the market share and is growing due to regulatory restrictions on animal testing and demand for alternative methods.

Top Companies in the North America In-Vitro Toxicology Testing Market

  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Merck KGaA
  • Eurofins Scientific
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Evotec S.E.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Catalent, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioIVT
  • Gentronix

Segments Covered in the Report

By Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging Technology
  • OMICS Technology

By Product

  • Consumables
  • Assays
  • Instruments
  • Software
  • Services

By Method

  • Cellular Assay
  • Live Cells
  • High Throughput / High Content Screening
  • Molecular Imaging
  • Confocal Microscopy
  • Others
  • Others
  • Fixed Cells
  • Biochemical Assay
  • In Silico
  • Ex-vivo

By Application

  • Systemic Toxicology
    • Acute Toxicity
    • Carcinogenicity
    • Developmental Toxicity
    • Others
  • Dermal Toxicity
    • Skin Irritation Test
    • Skin Sensitization Test
    • Skin Corrosion Test
    • Phototoxicity Test
    • Others
  • Endocrine Disruption
    • Dioxins
    • Phthalates
    • Polychlorinated biphenyls (PCB)
    • Ocular Toxicity
    • Intravitreal
    • Subretinal
    • Others
  • Others
    • Immunotoxicity
    • Reproductive Toxicity
    • Neurotoxicity
    • Epigenetic Alterations
    • Genotoxicity
    • Others

By End-use

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
    • Medical Devices
    • Others
  • Chemicals Industry
  • Food Industry

List of Tables & Figures

List of Tables

  • Table 1: North America In-Vitro Toxicology Testing Market Size, Technology, 2025-2035 (USD Million)
  • Table 2: North America Cell Culture Technology Market Size, 2025-2035 (USD Million)
  • Table 3: North America High Throughput Technology Market Size, 2025-2035 (USD Million)
  • Table 4: North America Molecular Imaging Technology Market Size, 2025-2035 (USD Million)
  • Table 5: North America OMICS Technology Market Size, 2025-2035 (USD Million)
  • Table 6: North America In-Vitro Toxicology Testing Market Size, Product, 2025-2035 (USD Million)
  • Table 7: North America Consumables Market Size, 2025-2035 (USD Million)
  • Table 8: North America Assays Market Size, 2025-2035 (USD Million)
  • Table 9: North America Instruments Market Size, 2025-2035 (USD Million)
  • Table 10: North America Software Market Size, 2025-2035 (USD Million)
  • Table 11: North America Services Market Size, 2025-2035 (USD Million)
  • Table 12: North America In-Vitro Toxicology Testing Market Size, Method, 2025-2035 (USD Million)
  • Table 13: North America Cellular Assay Market Size, 2025-2035 (USD Million)
  • Table 14: North America Live Cells Market Size, 2025-2035 (USD Million)
  • Table 15: North America High Throughput / High Content Screening Market Size, 2025-2035 (USD Million)
  • Table 16: North America Molecular Imaging Market Size, 2025-2035 (USD Million)
  • Table 17: North America Confocal Microscopy Market Size, 2025-2035 (USD Million)
  • Table 18: North America Fixed Cells Market Size, 2025-2035 (USD Million)
  • Table 19: North America Biochemical Assay Market Size, 2025-2035 (USD Million)
  • Table 20: North America In Silico Market Size, 2025-2035 (USD Million)
  • Table 21: North America Ex-vivo Market Size, 2025-2035 (USD Million)
  • Table 22: North America Others Method Market Size, 2025-2035 (USD Million)
  • Table 23: North America In-Vitro Toxicology Testing Market Size, Application, 2025-2035 (USD Million)
  • Table 24: North America Systemic Toxicology Market Size, 2025-2035 (USD Million)
  • Table 25: North America Dermal Toxicity Market Size, 2025-2035 (USD Million)
  • Table 26: North America Endocrine Disruption Market Size, 2025-2035 (USD Million)
  • Table 27: North America Others Application Market Size, 2025-2035 (USD Million)
  • Table 28: North America In-Vitro Toxicology Testing Market Size, End-use, 2025-2035 (USD Million)
  • Table 29: North America Pharmaceutical Industry Market Size, 2025-2035 (USD Million)
  • Table 30: North America Cosmetics & Household Products Market Size, 2025-2035 (USD Million)
  • Table 31: North America Academic Institutes & Research Laboratories Market Size, 2025-2035 (USD Million)
  • Table 32: North America Diagnostics Market Size, 2025-2035 (USD Million)
  • Table 33: North America Chemicals Industry Market Size, 2025-2035 (USD Million)
  • Table 34: North America Food Industry Market Size, 2025-2035 (USD Million)
  • Table 35: U.S. In-Vitro Toxicology Testing Market Size, 2025-2035 (USD Million)
  • Table 36: Canada In-Vitro Toxicology Testing Market Size, 2025-2035 (USD Million)
  • Table 37: Mexico In-Vitro Toxicology Testing Market Size, 2025-2035 (USD Million)
  • Table 38: North America Market Share, Technology, 2025 (%)
  • Table 39: North America Market Share, Product, 2025 (%)
  • Table 40: North America Market Share, Method, 2025 (%)
  • Table 41: North America Market Share, Application, 2025 (%)
  • Table 42: North America Market Share, End-use, 2025 (%)

List of Figures

  • Figure 1: North America In-Vitro Toxicology Testing Market Share, Technology, 2025 (%)
  • Figure 2: North America In-Vitro Toxicology Testing Market Share, Product, 2025 (%)
  • Figure 3: North America In-Vitro Toxicology Testing Market Share, Method, 2025 (%)
  • Figure 4: North America In-Vitro Toxicology Testing Market Share, Application, 2025 (%)
  • Figure 5: North America In-Vitro Toxicology Testing Market Share, End-use, 2025 (%)
  • Figure 6: North America In-Vitro Toxicology Testing Market Forecast, 2025-2035 (USD Million)
  • Figure 7: North America Cell Culture Technology Market Forecast, 2025-2035 (USD Million)
  • Figure 8: North America High Throughput Technology Market Forecast, 2025-2035 (USD Million)
  • Figure 9: North America Molecular Imaging Technology Market Forecast, 2025-2035 (USD Million)
  • Figure 10: North America OMICS Technology Market Forecast, 2025-2035 (USD Million)
  • Figure 11: North America Consumables Market Forecast, 2025-2035 (USD Million)
  • Figure 12: North America Assays Market Forecast, 2025-2035 (USD Million)
  • Figure 13: North America Instruments Market Forecast, 2025-2035 (USD Million)
  • Figure 14: North America Software Market Forecast, 2025-2035 (USD Million)
  • Figure 15: North America Services Market Forecast, 2025-2035 (USD Million)
  • Figure 16: U.S. In-Vitro Toxicology Testing Market Forecast, 2025-2035 (USD Million)
  • Figure 17: Canada In-Vitro Toxicology Testing Market Forecast, 2025-2035 (USD Million)
  • Figure 18: Mexico In-Vitro Toxicology Testing Market Forecast, 2025-2035 (USD Million)

Research Methodology